DISPOSITION CHARACTERISTICS OF MACROMOLECULES IN TUMOR-BEARING MICE

被引:232
作者
TAKAKURA, Y
FUJITA, T
HASHIDA, M
SEZAKI, H
机构
[1] Department of Basic Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto, 606, Sakyo-ku
关键词
hepatic uptake; Macromolecular compounds; physicochemical characteristics; systemic disposition; tumor targeting; urinary excretion;
D O I
10.1023/A:1015807119753
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
As part of the strategy for the design of macromolecular carriers for drug targeting, the disposition characteristics of macromolecules were studied in mice bearing tumors that served as target tissues. Eight kinds of macromolecules including four polysaccharides and four proteins with different molecular weights and electric charges were used; tissue distribution and tumor localization after intravenous injection were studied. Pharmacokinetic analysis revealed that the tissue radioactivity uptake rate index calculated in terms of clearance was different among the tested compounds; especially, the urinary radioactivity excretion clearances and the total hepatic radioactivity uptake clearances varied widely. Compounds with low molecular weights (approximately 10 kD) or positive charges showed lower tumor radioactivity accumulation; radioactivity was rapidly eliminated from the plasma via rapid urinary excretion or extensive hepatic uptake, respectively. On the other hand, large and negatively charged compounds, carboxymethyl dextran, bovine serum albumin, and mouse immunoglobulin G, showed higher radioactivity accumulation in the tumor (calculated total amounts were 15.6, 10.8, and 20.8% of the dose, respectively) and prolonged retention in the circulation. These results demonstrated that the total systemic exposure rather than the uptake rate index was correlated with total tumor uptake. Molecular weight and electric charge of the macromolecules significantly affected their disposition characteristics and, consequently, determined radioactivity accumulation in the tumor. It was concluded that a drug–carrier complex designed for systemic tumor targeting should be polyanionic in nature and larger than 70,000 in molecular weight. © 1990, Plenum Publishing Corporation. All rights reserved.
引用
收藏
页码:339 / 346
页数:8
相关论文
共 41 条
[1]  
ATSUMI R, 1987, CANCER RES, V47, P5546
[2]   PRELIMINARY MODEL FOR METHOTREXATE PHARMACOKINETICS [J].
BISCHOFF, KB ;
DEDRICK, RL ;
ZAHARKO, DS .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1970, 59 (02) :149-+
[3]   GLOMERULAR PERMSELECTIVITY - BARRIER FUNCTION BASED ON DISCRIMINATION OF MOLECULAR-SIZE AND CHARGE [J].
BRENNER, BM ;
HOSTETTER, TH ;
HUMES, HD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1978, 234 (06) :F455-F460
[4]  
BROWN BA, 1987, CANCER RES, V47, P1149
[5]   RENAL TUBULAR UPTAKE OF PROTEIN - EFFECT OF MOLECULAR CHARGE [J].
CHRISTENSEN, EI ;
RENNKE, HG ;
CARONE, FA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1983, 244 (04) :F436-F441
[6]   ANIMAL SCALE-UP [J].
DEDRICK, RL .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1973, 1 (05) :435-460
[7]  
FUJITA T, 1989, IN PRESS J CONTROL R
[8]  
HASHIDA M, 1984, DRUG METAB DISPOS, V12, P492
[9]  
HASHIDA M, 1981, GANN, V72, P226
[10]  
HASHIDA M, 1983, CHEM PHARM BULL, V31, P2055